Financials

  • Market Capitalization 126.87 M
  • Employee 118
  • Founded 2010
  • CEO N/A
  • Website www.cibus.com
  • Headquarter Delaware, United States
  • FIGI BBG00H1CJS11
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.63
Rapporto prezzo/fatturato
21.88

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3834
GNLX
Genelux Corporation - Common Stock
2.77 USD-3.82%+1.47%-6.10%-21.75%125.33 M USD
3840
VANI
Vivani Medical, Inc. - Common Stock
1.41 USD+0.71%-0.70%+6.82%+18.49%127.19 M USD
3845
ENGN
enGene Therapeutics Inc. - Common Stock
1.84 USD-3.66%+2.79%+6.36%-78.10%123.26 M USD
3847
PMN
ProMIS Neurosciences Inc. - Common Shares
13.87 USD-0.86%-6.16%-5.00%+2468.52%124.38 M USD

Notizie